STAT

NOVEMBER 7, 2023

But several years earlier, government officials recognized the risk: Soon after the FDA made its announcement, former Vice President Dick Cheney revealed in a “60 Minutes” interview that when his pacemaker was replaced in 2007, his doctors took precautions to make it hack-proof.

269

269

ALiEM - Pharm Pearls

JUNE 15, 2023

New York, NY: Springer; 2007. Auerbach’s wilderness medicine, 7e. Elsevier; 2017. Nelson LS, Shih RD, Balick MJ. In: Individual plants. Handbook of poisonous and injurious plants. Dasgupta A, Bourgeois L. Convallatoxin, the active cardiac glycoside of lily of the valley, minimally affects the ADVIA Centaur digoxin assay. J Clin Lab Anal.

Hospitals 246

Hospitals 246

Drug Patent Watch

JANUARY 26, 2025

Jazz Pharmaceuticals has been the sole manufacturer of Xyrem since 2007, but Avadel CNS Pharmaceuticals LLC has been challenging the patent's validity, arguing that it's no longer eligible for protection. This case has significant implications for the CNS market, where sleep disorders are a growing concern.

57

57

RX Note

DECEMBER 25, 2024

AHFS Drug Information Australian Medicines Handbook British National Formulary Micromedex Lexicomp Medscape Aronoff's Drug Prescribing in Renal Failure, 2007 Drug Prescribing in Renal Failure focuses on drug dosing in patients with impaired kidney function.

Dosage 40

Dosage Documentation Hospitals 40

ALiEM - Pharm Pearls

JANUARY 22, 2024

2007 Dec;21(4):997-1011, ix. Case Discussion Take-Home Points Consider Scrub Typhus in a patient presenting with eschars. Early empiric treatment with Doxycycline is life-saving. References Botelho-Nevers E, Raoult D. Fever of unknown origin due to rickettsioses. Infect Dis Clin North Am. doi: 10.1016/j.idc.2007.08.002. 2007.08.002.

Documentation 161

Documentation Hospitals 161

Putting Patients First Blog

SEPTEMBER 7, 2023

The Duchenne Registry began in 2007, when a group of thought leaders in the Duchenne muscular dystrophy community began discussing the need for a new kind of resource that would connect and serve the needs of the entire community. The average age at loss of ambulation for registrants who never used corticosteroids was 10.5

Drug Pricing 111

Drug Pricing 111

ALiEM - Pharm Pearls

SEPTEMBER 15, 2023

Am Fam Physician 2007; 76:86. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol 2010; 6:715. Trojian TH, Chu SM. Dupuytren’s disease: diagnosis and treatment.

Diabetes 152

Diabetes Clinic Management 152

ALiEM - Pharm Pearls

FEBRUARY 20, 2024

2007 Apr;19(2):155-9. PMID: 35287973. Devin R, Devin R, Garrett P, Anstey C. Managing cardiovascular collapse in severe flecainide overdose without recourse to extracorporeal therapy. Emerg Med Australas. doi: 10.1111/j.1742-6723.2006.00909.x. 1742-6723.2006.00909.x. PMID: 17448102.

183

183

pharmaphorum

SEPTEMBER 24, 2020

The charges relate to a period from 2007 until the end of 2010, when the Department of Justice alleges California-based Gilead routinely obtained data from the foundation detailing how much the foundation had spent for patients on Letairis.

Drug Pricing 98

Drug Pricing 98

RX Note

MARCH 31, 2025

A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne, 1990 The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study, 2007 Cosmeceuticals are intermediate products between licensed preparations containing medications and cosmetics.

Mayo Clinic 52

Mayo Clinic Community Pharmacies 52

Pharmacy Times

NOVEMBER 10, 2022

times more breast cancer survivors since the last estimate was conducted in 2007. Study shows there are 2.5

55

55

ALiEM - Pharm Pearls

SEPTEMBER 27, 2023

2007 Mar;5(1):64-74. Antimicrob Agents Chemother. 2020 Feb 21;64(3): e02167-19. PMID: 31871085. Moore AA, Whiteman EJ, Ward KT. Risks of combined alcohol/medication use in older adults. Am J Geriatr Pharmacother. PMID: 17608249. Meyer JH, Herlocher JE, Parisian J. Esophageal rupture after mushroom-alcohol ingestion. N Engl J Med.

Adverse Reactions 169

Adverse Reactions 169

pharmaphorum

FEBRUARY 11, 2021

A former AstraZeneca director, Wood founded commercial and medical benchmarking firm STEM in 2007 before selling it to UDG Healthcare for £84 million in 2016. Since leaving that company he has invested in a number of disruptive technology-driven pharma service providers.

116

116

pharmaphorum

NOVEMBER 9, 2020

The two companies have been working together since 2007 and Emisphere’s technology is already used under a licence agreement in the formulation for Rybelsus. Novo will buy all outstanding shares in Emisphere for $1.35 billion plus royalty obligations owed to MHR Fund Management, Emisphere’s largest shareholder, for $450 million.

Diabetes 111

Diabetes 111

European Pharmaceutical Review

JULY 5, 2023

Having been originally published in 2007, then revised in 2013, this latest 2023 edition addresses evolving standards and container types.

Pharmaceutical Manufacturing 96

Pharmaceutical Manufacturing Packaging Documentation Pharmaceutical Companies 96

pharmaphorum

AUGUST 20, 2020

Shorthose, Christian Dawson and Dean Woolley bought out the agency, which was had previously been acquired by healthcare communications company gyro in 2007 and then in 2016 by digital marketing company Dentsu Aegis Network. Ed Shorthose, managing director, said the move “felt right on every level”.

Communication 80

Communication 80

pharmaphorum

DECEMBER 14, 2022

Furthermore, Molina stated Jazz “suppressed generic competition and raised the price of Xyrem 841% between 2007 and 2014.” In 2007, Xyrem had an annual cost of $11,169, but in seven short years the cost had jumped to $106,215. Currently, the annual cost of Xyrem is $182,804, while Xywav is a little less at $168,508.

Controlled Substances 116

Controlled Substances 116

pharmaphorum

NOVEMBER 28, 2021

If ARISTOCRAT is successful, Sativex could become one of the first additions to NHS treatment for glioblastoma patients since temozolomide chemotherapy in 2007.

Chemotherapy 136

Chemotherapy Hospitals 136

pharmaphorum

AUGUST 20, 2020

The US government alleges that the payments occurred from 2007 until the end of 2015, to charities called The Assistance Fund (TAF) and Chronic Disease Fund (CDF). The allegation is that Teva’s subsidiaries Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc.

Specialty Pharmacies 115

Specialty Pharmacies Drug Pricing 115

pharmaphorum

MARCH 25, 2022

If trials are successful, nabiximols could become one of the first additions to treatment for glioblastoma patients since temozolomide chemotherapy in 2007.

Chemotherapy 98

Chemotherapy Pharmaceutical Manufacturing 98

pharmaphorum

OCTOBER 19, 2021

NICE began their work to update a 2007 clinical guideline on Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in January 2018. In the case of the update to the 2007 clinical guideline, those volunteers on the committee have not been able to reach a consensus. Leela Barham looks into the controversy.

131

131

pharmaphorum

DECEMBER 10, 2020

million international patient records from 320,000 clinical trials dating back to 2007. It already has access to around 6.1 million UK patient health records – equivalent to around 10% of the country’s total population – and the new agreement with Phesi will add around 13.5

Diabetes 98

Diabetes Drug Development 98

ID Stewardship

JUNE 18, 2023

ID Podcasts’ first podcast, “A Tour of the London Museum of Science,” was posted in June 2007. From there, our content grew rapidly – we commemorated our 100 th podcast in November 2009, and our first early smartphone apps were released in May 2010.

Hospitals 86

Hospitals 86

pharmaphorum

JUNE 11, 2021

Founded in 2007, Lucid Group is a strategic healthcare communications company based in London. Lucid Group has acquired US strategic brand consultancy DiD to expand its presence in the US.

Communication 69

Communication 69

pharmaphorum

JULY 29, 2021

“This strategy, which began in 2007, involved an overall price increase for liothyronine tablets of more than 6,000%,” said the CMA in a statement.

Drug Pricing 98

Drug Pricing 98

European Pharmaceutical Review

JUNE 28, 2024

1 There are several reasons why the adoption of continuous manufacturing (CM) for drugs lagged applications elsewhere.

52

52

European Pharmaceutical Review

SEPTEMBER 25, 2023

2007; 66(11-12): 963–8. 2007; 848(1): 79–87. 2007; 87(12): 2207–16. Evaluation of pi marker sources for CIEF characterization of a therapeutic antibody. Chromatographia. Flatman S, Alam I, Gerard J, Mussa N. Process analytics for purification of monoclonal antibodies. J Chromatogr B Biomed Appl. 2019; 91(6), 4107-4115.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

Big Molecule Watch

AUGUST 6, 2024

RANIBIZUMAB MIDAS was deemed highly similar to Genentech’s LUCENTIS (ranibizumab), which was authorized in the EU on January 22, 2007. RANIBIZUMAB MIDAS is a “duplicate” of Ranivisio, which was authorised in the EU on August 25, 2022. In the EU, “duplicate” medicines have identical composition and pharmaceutical form.

Biosimilars 59

Biosimilars Diabetes 59

European Pharmaceutical Review

OCTOBER 17, 2024

2007; 2(1):5-11. 2022 ; 17(11). Fitzcharles-Bowe C et al. Finger Injection With High-Dose (1:1,000) Epinephrine: Does It Cause Finger Necrosis And Should It Be Treated? Hand (N Y). Derived from IQVIA Claims Data, 2023. World Allergy Organization (WAO) White Book on Allergy 2011-2012: Executive Summary.

121

121

pharmaphorum

SEPTEMBER 24, 2020

million , the highest since the referral to treatment pathways began being measured in 2007. Elective procedures encompass all of the health service’s work which is not considered an emergency. Pre-outbreak, the waiting list for elective treatments stood at 4.4

Data Entry 111

Data Entry Documentation Hospitals 111

pharmaphorum

FEBRUARY 23, 2016

According to the European Commission and NIHR Clinical Research Network, between 2007 and 2011, delays for launching clinical trials rose by 90%. And with approximately one third of the clinical trial timeline spent in patient recruitment, delays in launching clinical trials will increase costs and drain resources.

Communication 52

Communication 52

pharmaphorum

NOVEMBER 19, 2020

George has been with the fund since 2007 and established its San Francisco office in 2010. GSK is the largest investor in the independent fund, which said it is the largest first-time VC fund to close in 2020 focused on US and European biotechs.

59

59

FADIC

AUGUST 11, 2023

” Example: A journal's impact factor for 2008 would be calculated by taking the number of citations in 2008 to articles that were published in 2007 and 2006 and dividing that number by the total number of articles published in that same journal in 2007 and 2006.

91

91

pharmaphorum

SEPTEMBER 20, 2021

Lucentis was first approved in the US in 2007 for wet AMD and grew quickly thereafter thanks to a string of additional indications, including DMO, myopic choroidal neovascularisation (mCNV) and macular oedema following retinal vein occlusion (RVO).

Biosimilars 72

Biosimilars Labelling Diabetes 72

Pharmaceutical Technology

MAY 19, 2023

Globally, the first rituximab biosimilar, Dr Reddy’s Laboratories’ Reditux, was approved in India in 2007. Rituxan received its first FDA approval in 1997 for the treatment of B-cell non-Hodgkin’s lymphoma (B-NHL) and reached peak global sales of $7.5bn in 2014. Rituxan’s success made it a prime target for biosimilar developers.

Biosimilars 59

Biosimilars 59

pharmaphorum

AUGUST 3, 2022

Lucentis was first approved in the US in 2007 for wet AMD and grew quickly thereafter as additional indications were approved. Roche has US marketing rights to the drug, and booked $1.3 billion in sales from it in 2021, while Novartis made $2.2

Biosimilars 59

Biosimilars Diabetes Labelling 59

RX Note

JULY 8, 2023

External Links Mayo Clinic - Plantar Fasciitis UpToDate - Plantar Fasciitis The efficacy of oral nonsteroidal anti-inflammatory medication (NSAID) in the treatment of plantar fasciitis: a randomized, prospective, placebo-controlled study, 2007 The effectiveness of manual stretching in the treatment of plantar heel pain: a systematic review, 2011 High-load (..)

Mayo Clinic 52

Mayo Clinic Community Pharmacies 52